Glenmark Pharma receives USFDA approval for Frovatriptan Succinate
Glenmark Pharma has received USFDA approval to manufacture and market therapeutical equivalent of Endo Pharmaceutical’s Frova tablets, used to treat migraine headaches. The drug Frovatriptan […]